Major depressive disorder, Neuroscience, Prefrontal cortex, Antidepressant and Mood disorders are her primary areas of study. Maura L. Furey combines subjects such as Hamilton Anxiety Rating Scale, Clinical psychology and Tricyclic antidepressant with her study of Major depressive disorder. Her study in Neuroscience focuses on Temporal cortex, Posterior cingulate, Functional magnetic resonance imaging, Stimulus modality and Visual system.
Her studies deal with areas such as Hippocampus and Transverse occipital sulcus as well as Temporal cortex. Her Functional magnetic resonance imaging research includes themes of Stimulus, Visual cortex and Face perception, Fusiform face area. In her study, Audiology, Bipolar disorder and Brain mapping is strongly linked to Amygdala, which falls under the umbrella field of Mood disorders.
Maura L. Furey spends much of her time researching Neuroscience, Major depressive disorder, Cholinergic, Antidepressant and Working memory. Her study in Cognition, Prefrontal cortex, Functional magnetic resonance imaging, Stimulus and Visual cortex are all subfields of Neuroscience. Her Visual cortex research integrates issues from Temporal cortex and Face perception.
Her Major depressive disorder study incorporates themes from Ketamine, Mood disorders, Audiology and Amygdala. In her study, which falls under the umbrella issue of Amygdala, Posterior cingulate is strongly linked to Hippocampus. Her research integrates issues of Cognitive psychology and Cerebral blood flow in her study of Working memory.
Her primary areas of investigation include Major depressive disorder, Antidepressant, Neuroscience, Ketamine and Psychiatry. Her biological study spans a wide range of topics, including Functional magnetic resonance imaging, Magnetoencephalography, Audiology and Amygdala. Her Antidepressant research is multidisciplinary, incorporating elements of Stimulus, Anesthesia, Randomization and Nucleus accumbens.
Many of her studies on Neuroscience involve topics that are commonly interrelated, such as Anticipation. Her research on Ketamine also deals with topics like
Her scientific interests lie mostly in Major depressive disorder, Psychiatry, Ketamine, Suicidal ideation and Amygdala. Her work carried out in the field of Major depressive disorder brings together such families of science as Antidepressant, Randomization, Anesthesia and Family history. Maura L. Furey does research in Psychiatry, focusing on Mood disorders specifically.
Her Ketamine research is multidisciplinary, relying on both Infralimbic cortex, Anterior cingulate cortex, Internal medicine and Mood. Endocrinology, Sleep disorder, Clinical psychology and Polysomnography are fields of study that intersect with her Suicidal ideation research. The various areas that she examines in her Amygdala study include Cognition, Psychomotor learning, Magnetoencephalography, Developmental psychology and Resting state fMRI.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Distributed and Overlapping Representations of Faces and Objects in Ventral Temporal Cortex
James V. Haxby;M. Ida Gobbini;Maura L. Furey;Alumit Ishai.
Science (2001)
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
Wayne C. Drevets;Joseph L. Price;Maura L. Furey.
Brain Structure & Function (2008)
Beyond sensory images: Object-based representation in the human ventral pathway
Pietro Pietrini;Maura L. Furey;Emiliano Ricciardi;M. Ida Gobbini.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder.
Teresa A. Victor;Maura L. Furey;Stephen J. Fromm;Arne Öhman.
Archives of General Psychiatry (2010)
Antidepressant Efficacy of the Antimuscarinic Drug Scopolamine: A Randomized, Placebo-Controlled Clinical Trial
Maura L. Furey;Wayne C. Drevets.
Archives of General Psychiatry (2006)
Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis
Gene E. Alexander;Maura L. Furey;Cheryl L. Grady;Pietro Pietrini.
American Journal of Psychiatry (1997)
Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease
Cheryl L. Grady;Maura L. Furey;Pietro Pietrini;Barry Horwitz.
Brain (2001)
Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease
Vicente Ibáñez;Pietro Pietrini;Gene E. Alexander;Maura L. Furey.
Neurology (1998)
Cholinergic enhancement and increased selectivity of perceptual processing during working memory.
Maura L. Furey;Pietro Pietrini;James V. Haxby.
Science (2000)
Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial.
Wayne C. Drevets;Maura L. Furey.
Biological Psychiatry (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
IMT Institute for Advanced Studies Lucca
University of Arizona
Cincinnati Children's Hospital Medical Center
National Institutes of Health
Johnson & Johnson (United States)
IMT Institute for Advanced Studies Lucca
New York University
National Institutes of Health
National Institutes of Health
Dartmouth College
The University of Texas at Austin
Tokyo University of Science
Nankai University
Yonsei University
University of Tübingen
Ludwig-Maximilians-Universität München
University of California, Los Angeles
British Antarctic Survey
Oregon Health & Science University
Centers for Disease Control and Prevention
Finnish Institute for Health and Welfare
Medical University of Graz
Erasmus University Rotterdam
Hochschule Hannover
University of Houston
Friedrich Schiller University Jena